Literature DB >> 32170348

CXCR7 suppression modulates macrophage phenotype and function to ameliorate post-myocardial infarction injury.

Junshi Zhang1, Ying Zhang2, Shifeng Xin2, Min Wu2, Yaling Zhang2, Lihua Sun3.   

Abstract

OBJECTIVE: Myocardial infarction (MI) is one of the primary causes leading to heart failure in coronary artery disease. However, the mechanisms of macrophage that dominate pathogenesis of MI remain unclear.
METHODS: Mice were induced with MI and pretreated with adenovirus containing indicated shRNA. Post-MI injuries were evaluated by echocardiography. BMDMs and post-MI LV macrophages were used to assess the significance of CXCR7. Macrophages' migration was examined by chemotaxis assay, Cytokine production, phosphorylation of ERK1/2, p38 MAPK and JNK were measured by ELISA.
RESULTS: CXCR7 in macrophages was up-regulated during M1 polarization and following MI in the murine model, with positive correlation with M1 markers but not M2 markers. Besides, CXCR7 down-regulation abolished macrophage M1 polarization. In addition, CXCR7 but not CXCR3 or CXCR4 controlled SDF-1 and I-TAC-mediated chemotaxis and inflammation in M1-like macrophages post-MI, signaling through activating ERK1/2, whereas p38 MAPK and JNK were not involved. Moreover, silencing CXCR7 ameliorated cardiac dysfunction by attenuating infarct area, LVEF and LVFS post-MI along with reduction of CXCR7 expression and ERK1/2 phosphorylation.
CONCLUSIONS: Our data demonstrate that CXCR7 suppression inhibits macrophages M1 polarization, chemotaxis and inflammation to ameliorate post-MI injury, providing novel insights and promising therapy approaches in post-MI treatment.

Entities:  

Keywords:  CXCR7; Chemotaxis; Extracellular signal-regulated kinase (ERK); Macrophage; Myocardial infarction (MI)

Year:  2020        PMID: 32170348     DOI: 10.1007/s00011-020-01335-z

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  5 in total

Review 1.  Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases.

Authors:  Vincent Duval; Paul Alayrac; Jean-Sébastien Silvestre; Angélique Levoye
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-29       Impact factor: 6.055

Review 2.  Multiple roles of cardiac macrophages in heart homeostasis and failure.

Authors:  Aneta Moskalik; Justyna Niderla-Bielińska; Anna Ratajska
Journal:  Heart Fail Rev       Date:  2021-08-13       Impact factor: 4.654

3.  Endothelial ACKR3 drives atherosclerosis by promoting immune cell adhesion to vascular endothelium.

Authors:  Selin Gencer; Yvonne Döring; Yvonne Jansen; Soyolmaa Bayasgalan; Yi Yan; Mariaelvy Bianchini; Ismail Cimen; Madeleine Müller; Linsey J F Peters; Remco T A Megens; Philipp von Hundelshausen; Johan Duchene; Patricia Lemnitzer; Oliver Soehnlein; Christian Weber; Emiel P C van der Vorst
Journal:  Basic Res Cardiol       Date:  2022-06-08       Impact factor: 12.416

Review 4.  Signaling pathways and targeted therapy for myocardial infarction.

Authors:  Qing Zhang; Lu Wang; Shiqi Wang; Hongxin Cheng; Lin Xu; Gaiqin Pei; Yang Wang; Chenying Fu; Yangfu Jiang; Chengqi He; Quan Wei
Journal:  Signal Transduct Target Ther       Date:  2022-03-10

Review 5.  Atypical Roles of the Chemokine Receptor ACKR3/CXCR7 in Platelet Pathophysiology.

Authors:  Madhumita Chatterjee
Journal:  Cells       Date:  2022-01-09       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.